The (pro)renin receptor (PRR) plays an essential role in the early development of the central nervous system by activating the Wnt/β-catenin signaling pathway. The authors investigated the potential role of the PRR in the pathogenesis of glioma.
The authors performed immunohistochemical analysis to detect both the PRR and isocitrate dehydrogenase 1 with mutations involving arginine 132 (IDH1R132H) in paraffin sections of 31 gliomas. Expression of the PRR and Wnt pathway components in cultured human glioma cell lines (U251MG, U87MG, and T98G) was measured using Western blotting. The effects of PRR short interfering RNA (siRNA) on glioma cell proliferation (WST-1 assay and direct cell counting) and apoptosis (flow cytometry and the caspase-3 assay) were also examined.
PRR expression was significantly higher in glioblastoma than in normal tissue or in lower grade glioma, regardless of IDH1R132H mutation. PRR expression was also higher in human glioblastoma cell lines than in human astrocytes. PRR expression showed a significant positive correlation with the Ki-67 labeling index, while it had a significant negative correlation with the survival time of glioma patients. Treatment with PRR siRNA significantly reduced expression of Wnt2, activated β-catenin, and cyclin D1 by human glioblastoma cell lines, and it reduced the proliferative capacity of these cell lines and induced apoptosis.
This is the first evidence that the PRR has an important role in development of glioma by aberrant activation of the Wnt/β-catenin signaling pathway. This receptor may be both a prognostic marker and a therapeutic target for glioma.
Correspondence Masaaki Kouchi, Department of Neurological Surgery, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan. email: firstname.lastname@example.org.INCLUDE WHEN CITING Published online January 6, 2017; DOI: 10.3171/2016.9.JNS16431.Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
AlexsonTO, HitoshiS, ColesBL, BernsteinA, van der KooyD: Notch signaling is required to maintain all neural stem cell populations—irrespective of spatial or temporal niche. 28:34–48, 20061650830210.1159/000090751)| false
HiroseT, MoriN, TotsuneK, MorimotoR, MaejimaT, KawamuraT, : Gene expression of (pro)renin receptor is upregulated in hearts and kidneys of rats with congestive heart failure. 30:2316–2322, 200910.1016/j.peptides.2009.09.01519765626)| false
IchimuraK, PearsonDM, KocialkowskiS, BäcklundLM, ChanR, JonesDT, : IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. 11:341–347, 20091943594210.1215/15228517-2009-025)| false
KoopmanGReutelingspergerCPKuijtenGAKeehnenRMPalsSTvan OersMH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood84:1415–14201994
KoopmanG, ReutelingspergerCP, KuijtenGA, KeehnenRM, PalsST, van OersMH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. 84:1415–1420, 1994)| false
LiYM, SukiD, HessK, SawayaR: The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?. 124:977–988, 20162649594110.3171/2015.5.JNS142087)| false
LiuX, WangL, ZhaoS, JiX, LuoY, LingF: β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells. 28:608–614, 201110.1007/s12032-010-9476-520300972)| false
MarshJC, GoldmanS, ZielE, BregmanC, DiazA, ByrneR, : Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases. 122:105–110, 20152550296210.1007/s11060-014-1682-0)| false
NguyenG, DelarueF, BurckléC, BouzhirL, GillerT, SraerJD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. 109:1417–1427, 200210.1172/JCI021427612045255)| false
OhbaK, SuzukiT, NishiyamaH, KanekoK, HiroseT, TotsuneK, : Expression of (pro)renin receptor in breast cancers and its effect on cancer cell proliferation. 35:117–126, 201410.2220/biomedres.35.117)| false
PulvirentiT, Van Der HeijdenM, DromsLA, HuseJT, TabarV, HallA: Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas. 71:7280–7290, 201110.1158/0008-5472.CAN-11-153121990322)| false
StuppRHegiMEMasonWPvan den BentMJTaphoornMJJanzerRC: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol10:459–4662009
StuppR, HegiME, MasonWP, van den BentMJ, TaphoornMJ, JanzerRC, : Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. 10:459–466, 200910.1016/S1470-2045(09)70025-7)| false
SunMZ, OhT, IvanME, ClarkAJ, SafaeeM, SayeghET, : Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. 122:1144–1150, 201510.3171/2014.9.JNS1419325768833)| false
TakahashiK, YamamotoH, HiroseT, HiraishiK, ShojiI, ShibasakiA, : Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy. 31:1405–1408, 201010.1016/j.peptides.2010.04.00320385187)| false
van EngelandM, NielandLJ, RamaekersFC, SchutteB, ReutelingspergerCP: Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. 31:1–9, 199810.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R)| false